Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon C H Yu

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Cancer Management and Research|May 2, 2019
Correlations of health-related quality of life with serum inflammatory indicators IL-8 and mIBI in patients with hepatocellular carcinomaLeung Li, Stephen L Chan, Frankie Mo, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 29, 2013
Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic massStephen L Chan, Frankie Mo, Philip J Johnson, et al.
The Annals of Thoracic Surgery|January 4, 2014
Delayed stent deformity and fracture of Djumbodis dissection systemRandolph H L Wong, Simon C H Yu, Rainbow W H Lau, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 15, 2008
Transarterial ethanol ablation of hepatocellular carcinoma with lipiodol ethanol mixture: phase II studySimon C H Yu, Edwin P Hui, John Wong, et al.
Cancer|June 23, 2017
A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinomaStephen L Chan, Winnie Yeo, Frankie Mo, et al.
Clinical Chemistry|July 27, 2002
Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individualsEnders K O Ng, Nancy B Y Tsui, Nicole Y L Lam, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 21, 2018
Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selectionCharing C N Chong, Kit-Fai Lee, Cheuk-Man Chu, et al.
Investigational New Drugs|April 15, 2021
A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinomaStephen L Chan, Paul N M Cheng, Angela M Liu, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|February 5, 2013
Angioplasty and stenting for intracranial atherosclerotic stenosis: position statement of the Hong Kong Society of Interventional and Therapeutic NeuroradiologySimon C H Yu, Harold K M Cheng, P W Cheng, et al.
BMC Cancer|May 13, 2015
Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for responseWinnie Yeo, Stephen L Chan, Frankie K F Mo, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Cancer Management and Research|May 2, 2019
Correlations of health-related quality of life with serum inflammatory indicators IL-8 and mIBI in patients with hepatocellular carcinomaLeung Li, Stephen L Chan, Frankie Mo, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 29, 2013
Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic massStephen L Chan, Frankie Mo, Philip J Johnson, et al.
The Annals of Thoracic Surgery|January 4, 2014
Delayed stent deformity and fracture of Djumbodis dissection systemRandolph H L Wong, Simon C H Yu, Rainbow W H Lau, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 15, 2008
Transarterial ethanol ablation of hepatocellular carcinoma with lipiodol ethanol mixture: phase II studySimon C H Yu, Edwin P Hui, John Wong, et al.
Cancer|June 23, 2017
A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinomaStephen L Chan, Winnie Yeo, Frankie Mo, et al.
Clinical Chemistry|July 27, 2002
Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individualsEnders K O Ng, Nancy B Y Tsui, Nicole Y L Lam, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 21, 2018
Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selectionCharing C N Chong, Kit-Fai Lee, Cheuk-Man Chu, et al.
Investigational New Drugs|April 15, 2021
A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinomaStephen L Chan, Paul N M Cheng, Angela M Liu, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|February 5, 2013
Angioplasty and stenting for intracranial atherosclerotic stenosis: position statement of the Hong Kong Society of Interventional and Therapeutic NeuroradiologySimon C H Yu, Harold K M Cheng, P W Cheng, et al.
BMC Cancer|May 13, 2015
Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for responseWinnie Yeo, Stephen L Chan, Frankie K F Mo, et al.
Pageof 10